Open AccessClinical effects of apatinib mesylate for treatment of multiple brain micrometastases: Two case reports
Author(s) -
Junhui Guo,
YuanYuan Wang,
Jiangwei Zhang,
Peimin Liu,
Yue Hao,
Hai-Rui Duan
Publication year - 2020
Publication title -
world journal of clinical cases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.368
H-Index - 10
ISSN - 2307-8960
DOI - 10.12998/wjcc.v8.i7.1326
Subject(s) - apatinib , medicine , mesylate , tyrosine kinase inhibitor , adverse effect , oncology , chemotherapy , cancer , chemistry , organic chemistry
Apatinib is a small-molecule multitargeted tyrosine kinase inhibitor. Apatinib has demonstrated encouraging antitumor activities. This study aimed to observe the efficacy and safety of apatinib for the treatment of multiple brain micrometastases.